Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Corticosteroids in Severe Influenza Pneumonia
2025-524976-40-00Phase 3Authorised
- Sponsor
- CHR Metz-Thionville
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza pneumonia comparing Dexamethasone + standard of care with Placebo + standard of care (2 arms). Primary endpoint: Primary hierarchical composite endpoint at day 28. Planned start Jun 2026; status: authorised.
02
Drugs
dexamethasone
03
Conditions
influenza pneumonia
Beyond the preview
Go deeper on 2025-524976-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524976-40-00.